Procedures for whole-mount immunohistochemistry and in situ hybridization of immature mammalian CNS.
Whole-mount labeling techniques for staining in invertebrates or lower vertebrates cannot simply be applied to the mammalian central nervous system (CNS) because of its large size. Such techniques if possible would offer advantages over conventional methods based on sections since an immediate and 3-dimensional view of the stained components in a transparent CNS is provided. It thereby becomes possible to survey and count large number of cells and fibers in their natural relationships. The aim of our experiments is to follow developing and regenerating expression of proteins and mRNAs in the CNS of mouse embryos and newborn opossums (Monodelphis domestica). Accordingly, we have devised three techniques applicable to whole-mounts: (i) An effective immunohistochemical procedure. This comprises a peroxidase-antiperoxidase method (PAP-WM) based on protocols initially developed for Xenopus embryos and oocytes, including a variation to detect exogenously applied nucleotide analogs such as 5-bromo-2'-deoxyuridine (PAP[BrdU]-WM). For greater resolution we have introduced a novel gold-silver method (IGSS-WM). (ii) An in situ hybridization procedure (ISH[PAP]-WM) which combines PAP-WM with protocols described for Xenopus. (iii) A deconvolution (optical sectioning) procedure which improves resolution for bright-field microscopy. We show that reliable whole-mount staining can be obtained using isolated CNS aged up to mouse embryonic day 17 and newborn opossum up to 15 days. Examples are shown of preparations in which one can directly localize nerve cells containing neurotransmitters, cytoskeletal proteins, nucleotide analogs and growth factor messages.
Luque
J M
JM
Department of Pharmacology, Biocenter of the University of Basel, Switzerland. luque@ubaclu.unibas.ch
Adams
W B
WB
Nicholls
J G
JG
D000818:Animals; D001973:Bromodeoxyuridine; D002490:Central Nervous System / Q000033:anatomy & histology* / Q000378:metabolism*; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D005727:Ganglia, Spinal / Q000166:cytology / Q000201:enzymology / Q000254:growth & development; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry / Q000379:methods*; D017403:In Situ Hybridization / Q000379:methods*; D007202:Indicators and Reagents; D051379:Mice; D009893:Opossums / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D007202:Indicators and Reagents; D016222:Fibroblast Growth Factor 2; D014446:Tyrosine 3-Monooxygenase; D001973:Bromodeoxyuridine